Anthony (Abe) DeSantis, MD, clinical professor (Metabolism, Endocrinology and Nutrition) has received a 2016 UW Medicine Cares Award. The UW Medicine Cares Award was established in 2013 to formally recognize and celebrate the accomplishments and excellence of those in the UW Medicine community who consistently exemplify the UW Medicine Service Culture Guidelines.

Santica Marcovina, PhD, research professor (Metabolism, Endocrinology and Nutrition) is co-author of “Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials” in The Lancet. 

A study led by Michael Schwartz, MD, professor, published in Nature, showed that obese and diabetic mice that got a single shot of a growth-promoting peptide directly into their brains experienced lasting remission from the metabolic disorder without any sustained changes to their diet or their weight.

Steven Kahn, MB, ChB, professor, will receive the Outstanding Achievement in Clinical Diabetes Research Award from the American Diabetes Association. This award recognizes exceptional contributions in patient-oriented, clinical outcomes research that have had a significant impact on diabetes prevention and treatment.

Michael Schwartz, MD, professor, has received a $3.1 million grant from Novo Nordisk to collaborate on exploring the role of the brain in regulating blood glucose and obesity. The research will be conducted over the next three years, at South Lake Union research campus in Seattle, and at Novo Nordisk’s research facilities in Måløv, Denmark.

Karin Bornfeldt, PhD, professor, has been awarded a new R01 from the NIH/NHLBI for her project: “Obesity and Arterial Metabolism.” The overall hypothesis is that expression of the glucose transporter GLUT1 is of critical importance for the obesity-induced arterial metabolic signature, smooth muscle cell phenotype, and obesity-accelerated atherosclerosis.